HOW MANY MORE OZEMPIC-LIKE DRUGS ARE IN THE PIPELINE — HERE'S WHAT RESEARCHERS ARE WORKING ON

Summary from the TLDR newsletter

Semaglutide has proved so successful that its manufacturer is unable to keep up with demand. There is currently a tsunami of clinical trials for new drugs that also operate on the gut-brain axis and re-create the action of other intestinal and pancreatic hormones. This article discusses the state of the industry and new developments on the horizon. These drugs remain inaccessible for many people due to cost.